Stevanato Group Spa

Mid-Cap Stocks Healthcare Stocks Best Dividend Stocks

$17.24

+0.37 (+2.19%)

As of Jun 24, 9:56 PM ET ·

STVN vs Life Sciences Tools & Services Average

P/E Ratio

STVN 29.6

Avg 46.0

Profit Margin

STVN 11.8%

Avg 10.1%

Rev Growth

STVN +6.4%

Avg +4.5%

Div Yield

STVN 0.35%

Avg 0.54%

Life Sciences Tools & Services Peers

1012 stocks in sector

Symbol	Name	Price	Change %	Market Cap	P/E	Margin	Growth	Div Yield	Analyst
STVN	Stevanato Group Spa	$17.24	+2.19%	4.79B	29.6	11.8%	+6.4%	0.35%	Current
TMO	Thermo Fisher Scientific Inc	$492.20	+4.87%	172.66B	25.2	15.0%	-0.3%	0.40%	Strong buy	Compare
DHR	Danaher Corp	$188.87	+5.53%	125.40B	34.0	14.7%	-2.7%	0.90%	Strong buy	Compare
A	Agilent Technologies Inc	$131.63	+3.92%	35.89B	25.4	18.8%	+0.5%	0.80%	Strong buy	Compare
WAT	Waters Corp	$369.18	+3.35%	34.90B	77.7	20.3%	+2.1%	—	Buy	Compare
IQV	Iqvia Holdings Inc	$185.62	+8.37%	28.00B	20.2	8.3%	+4.2%	—	Strong buy	Compare
ILMN	Illumina Inc	$175.09	+6.16%	24.50B	28.7	19.6%	-1.8%	—	Buy	Compare
WST	West Pharmaceutical Services	$340.41	+1.20%	23.17B	42.7	16.1%	+2.1%	0.33%	Strong buy	Compare
MTD	Mettler-Toledo International	$1,203.18	+4.02%	23.13B	26.4	21.6%	+0.9%	—	Hold	Compare
MEDP	Medpace Holdings Inc	$512.79	+8.30%	13.14B	28.6	17.8%	+20.1%	—	Hold	Compare
ICLR	Icon Plc	$158.17	+10.86%	11.18B	48.7	2.8%	+2.2%	—	Buy	Compare
RVTY	Revvity Inc	$105.63	+5.74%	11.16B	46.5	8.5%	-4.8%	0.28%	Hold	Compare
TEM	Tempus Ai Inc	$51.94	+6.85%	9.13B	—	-19.3%	+58.3%	—	Buy	Compare
TECH	Bio-Techne Corp	$58.88	+4.65%	9.07B	83.6	6.0%	+3.3%	0.55%	Buy	Compare
CRL	Charles River Laboratories	$202.10	+8.31%	8.91B	—	-3.6%	+0.3%	—	Buy	Compare
BRKR	Bruker Corp	$58.44	+6.04%	8.71B	—	-0.3%	+10.7%	0.35%	Buy	Compare
BIO	Bio-Rad Laboratories-A	$280.05	+3.60%	7.65B	45.3	29.4%	-2.7%	—	Hold	Compare
QGEN	Qiagen N.V.	$38.73	+4.11%	7.61B	18.9	20.3%	-0.8%	0.71%	Hold	Compare
RGEN	Repligen Corp	$138.40	+9.52%	7.45B	144.9	6.6%	-2.7%	—	Strong buy	Compare
AVTR	Avantor Inc	$9.69	+2.76%	6.54B	—	-8.1%	-4.5%	—	Hold	Compare
SHC	Sotera Health Co	$16.69	+5.37%	4.51B	38.3	6.7%	+5.1%	—	Strong buy	Compare